MED
Medifast Inc

1,775
Mkt Cap
$115.74M
Volume
63,505.00
52W High
$15.46
52W Low
$10.10
PE Ratio
-6.19
MED Fundamentals
Price
$10.42
Prev Close
$10.53
Open
$10.31
50D MA
$11.19
Beta
0.62
Avg. Volume
232,168.60
EPS (Annual)
-$1.70
P/B
0.58
Rev/Employee
$1.02M
$39.30
Loading...
Loading...
News
all
press releases
Diageo 1H'26 Earnings & Sales Decline Y/Y, Organic Sales Drop 2.8%
DEO's 1H'26 EPS fell 2.5% as U.S. weakness and tequila slump offset growth in RTDs, Guinness and MENA, with FY26 sales seen down 2-3%.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Boston Beer's Q4 Loss Narrows, Lower Volumes Hurt Revenues
SAM posts a narrower Q4 loss than expected as revenues fall 4% on weak volumes, while 2026 guidance flags tariff and margin pressures.
Zacks·5d ago
News Placeholder
Freshpet Stock Up 5% After Reporting Q4 Earnings Beat Estimates
FPRT beats Q4 earnings as volumes rose 9.7% and EBITDA climbed 16%, with shares up 5.5% on a solid 2026 outlook.
Zacks·6d ago
News Placeholder
Medifast (NYSE:MED) Downgraded to "Sell" Rating by Wall Street Zen
Wall Street Zen cut Medifast from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·9d ago
News Placeholder
Scientific Evidence Demonstrates OPTAVIAs Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients
As part of its continued focus on improving metabolic health, Medifast (NYSE: MED) today announced that OPTAVIAs comprehensive metabolic health system is available for reimbursement on select...
Business Wire·10d ago
News Placeholder
Stephens Lowers Medifast (NYSE:MED) Price Target to $12.00
Stephens reduced their target price on shares of Medifast from $15.00 to $12.00 and set an "equal weight" rating for the company in a research note on Thursday...
MarketBeat·11d ago
News Placeholder
Medifast Q4 Loss Wider Than Expected, Revenues Decline 37% Y/Y
MED posts a wider quarterly loss as revenue tumbles 36.9% on a sharp drop in OPTAVIA coaches, despite beating revenue estimates.
Zacks·12d ago
News Placeholder
Medifast (NYSE:MED) Posts Earnings Results, Beats Expectations By $0.21 EPS
Medifast (NYSE:MED - Get Free Report) posted its quarterly earnings data on Tuesday. The specialty retailer reported ($0.55) earnings per share for the quarter, topping analysts' consensus estimates...
MarketBeat·12d ago
News Placeholder
Medifast Q4 Earnings Call Highlights
Medifast (NYSE:MED) reported fourth-quarter and full-year 2025 results while outlining continued efforts to reposition the business around metabolic health, highlighting early signs of improving...
MarketBeat·13d ago
News Placeholder
Medifast (NYSE:MED) Updates Q1 2026 Earnings Guidance
Medifast (NYSE:MED) updated its first quarter 2026 earnings guidance. The company provided EPS guidance of -0.700--0.15 for the period, compared to the consensus estimate of -0.260. The company also...
MarketBeat·13d ago
<
1
2
...
>

Latest MED News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.